Premium
Part V. What Are Appropriate Surrogate Markers of Neurological Decline and What Experimental Models Are Best to Assess the Efficacy of Hormone/Estrogen Therapy?
Publication year - 2005
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1196/annals.1347.026
Subject(s) - citation , annals , estrogen , medicine , surrogate endpoint , hormone replacement therapy (female to male) , hormone therapy , bioinformatics , computer science , psychology , library science , classics , history , biology , cancer , breast cancer , testosterone (patch)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom